AAAAAA
Results:
1-7
|
Results: 7
Authors:
Verstovsek, S
Estey, E
Manshouri, T
Keating, M
Kantarjian, H
Giles, FJ
Albitar, M
Citation: S. Verstovsek et al., High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome, LEUK LYMPH, 42(3), 2001, pp. 511-516
Authors:
Verstovsek, S
Kantarjian, H
Estey, E
Aguayo, A
Giles, FJ
Manshouri, T
Koller, C
Estrov, Z
Freireich, E
Keating, M
Albitar, M
Citation: S. Verstovsek et al., Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome, LEUKEMIA, 15(8), 2001, pp. 1165-1170
Authors:
Verstovsek, S
Manshouri, T
Kantarjian, H
Giles, FJ
Keating, M
Estey, E
Albitar, M
Citation: S. Verstovsek et al., Highly reproducible detection and semi-quantification of telomerase activity, BIOTECHNIQU, 30(5), 2001, pp. 930
Authors:
Verstovsek, S
Kantarjian, H
Aguayo, A
Manshouri, T
Freireich, E
Keating, M
Estey, E
Albitar, M
Citation: S. Verstovsek et al., Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome, BR J HAEM, 114(2), 2001, pp. 290-295
Authors:
Verstovsek, S
Verschraegen, CF
Edwards, CL
Malpica, A
Kavanagh, JJ
Ross, MI
Strom, EA
Jhingran, A
Theriault, RL
Kudelka, AP
Citation: S. Verstovsek et al., Synchronous primary cancers of the breast and cervix: Planning multidisciplinary primary treatment, AM J CL ONC, 23(1), 2000, pp. 99-103
Authors:
Ehrke, MJ
Verstovsek, S
Maccubbin, DL
Ujhazy, P
Zaleskis, G
Berleth, E
Mihich, E
Citation: Mj. Ehrke et al., Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice, INT J CANC, 87(1), 2000, pp. 101-109
Authors:
Zavadova, E
Loercher, A
Verstovsek, S
Verschraegen, CE
Micksche, M
Freedman, RS
Citation: E. Zavadova et al., The role of macrophages in antitumor defense of patients with ovarian cancer, HEMAT ONCOL, 13(1), 1999, pp. 135
Risultati:
1-7
|